» Articles » PMID: 35574459

Autonomic Neural Circuit and Intervention for Comorbidity Anxiety and Cardiovascular Disease

Overview
Journal Front Physiol
Date 2022 May 16
PMID 35574459
Authors
Affiliations
Soon will be listed here.
Abstract

Anxiety disorder is a prevalent psychiatric disease and imposes a significant influence on cardiovascular disease (CVD). Numerous evidence support that anxiety contributes to the onset and progression of various CVDs through different physiological and behavioral mechanisms. However, the exact role of nuclei and the association between the neural circuit and anxiety disorder in CVD remains unknown. Several anxiety-related nuclei, including that of the amygdala, hippocampus, bed nucleus of stria terminalis, and medial prefrontal cortex, along with the relevant neural circuit are crucial in CVD. A strong connection between these nuclei and the autonomic nervous system has been proven. Therefore, anxiety may influence CVD through these autonomic neural circuits consisting of anxiety-related nuclei and the autonomic nervous system. Neuromodulation, which can offer targeted intervention on these nuclei, may promote the development of treatment for comorbidities of CVD and anxiety disorders. The present review focuses on the association between anxiety-relevant nuclei and CVD, as well as discusses several non-invasive neuromodulations which may treat anxiety and CVD.

Citing Articles

Determinants of generalized anxiety and construction of a predictive model in patients with chronic obstructive pulmonary disease.

Zhao Y, Liu W, Zhang Q World J Psychiatry. 2025; 15(2):98447.

PMID: 39974476 PMC: 11758039. DOI: 10.5498/wjp.v15.i2.98447.


A Mendelian randomization study of the effect of mental disorders on cardiovascular disease.

Yu Y, Yang X, Wu J, Hu G, Bai S, Yu R Front Cardiovasc Med. 2024; 11:1329463.

PMID: 38887450 PMC: 11180800. DOI: 10.3389/fcvm.2024.1329463.


Prevalence and predictors of preoperative cardiac autonomic dysfunction among elective neurosurgical patients: A prospective observational study.

Sangeetha R, Chakrabarti D, Sriganesh K, Mahendranath M, Sathyaprabha T, Srinivas D Indian J Anaesth. 2024; 68(4):380-386.

PMID: 38586253 PMC: 10993939. DOI: 10.4103/ija.ija_722_23.


Anxiety disorder and cardiovascular disease: a two-sample Mendelian randomization study.

Peng B, Meng H, Guo L, Zhu J, Kong B, Qu Z ESC Heart Fail. 2024; 11(2):1174-1181.

PMID: 38279876 PMC: 10966263. DOI: 10.1002/ehf2.14676.

References
1.
Bandelow B, Michaelis S . Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015; 17(3):327-35. PMC: 4610617. View

2.
Gianaros P, Sheu L, Remo A, Christie I, Crtichley H, Wang J . Heightened resting neural activity predicts exaggerated stressor-evoked blood pressure reactivity. Hypertension. 2009; 53(5):819-25. PMC: 2674279. DOI: 10.1161/HYPERTENSIONAHA.108.126227. View

3.
Saha S . Role of the central nucleus of the amygdala in the control of blood pressure: descending pathways to medullary cardiovascular nuclei. Clin Exp Pharmacol Physiol. 2005; 32(5-6):450-6. DOI: 10.1111/j.1440-1681.2005.04210.x. View

4.
Gurel N, Huang M, Wittbrodt M, Jung H, Ladd S, Shandhi M . Quantifying acute physiological biomarkers of transcutaneous cervical vagal nerve stimulation in the context of psychological stress. Brain Stimul. 2019; 13(1):47-59. PMC: 8252146. DOI: 10.1016/j.brs.2019.08.002. View

5.
Herman J, Figueiredo H, Mueller N, Ulrich-Lai Y, Ostrander M, Choi D . Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003; 24(3):151-80. DOI: 10.1016/j.yfrne.2003.07.001. View